Megestrol Acetate, #203139

Product Category

US FDA-Approved Medicine

Formulation

MEGESTROL ACETATE: 125 mg/mL Oral suspension

Delivery Method

Oral Suspension

Status

Prescription

ANDA #

203139

Approval Date

20140827

Therapeutic Equivalents

Manufacturers